Replay available

Koninklijke Philips N.V. NY Registry Shares (PHG) Q3 2025 Earnings Call

Koninklijke Philips N.V. NY Registry Shares (NYSE: PHG) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 4:00 AMendedReplay
Koninklijke Philips N.V. NY Registry Shares (PHG) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Durga Duraisamy

Head of Investor Relations

Roy Jacobs

Chief Executive Officer

Charlotte Hanneman

Chief Financial Officer

Julien Dormois

Analyst, Jefferies

Hugo Solvete

Analyst, BNP Paribas Exane

Hassan Al-Bakir

Analyst, Barclays

David Adlington

Analyst, J.P. Morgan

Graham Doyle

Analyst, UBS

Veronica Dubajova

Analyst, Citi

Richard Felton

Analyst, Goldman Sachs

Veeam He

Analyst, ABN Amro

Falco Frederick

Analyst, Deutsche Bank

Replay transcript excerpt

Welcome to the Royal Philips Third Quarter 2025 Results Conference Call on Tuesday, November 4th, 2025. During the call, hosted by Mr. Roy Jacobs, CEO, and Ms. Charlotte Hanneman, CFO, all participants will be in a listen-only mode. After the introduction, there will be an opportunity to ask questions. Please note that this call will be recorded and a replay will be available on the Investor Relations website of Royal Philips. I will now hand the conference over to Ms. Durga Duraisamy, Head of Investor Relations. Please go ahead, Madam. Hello, everyone. Welcome to Philips Results webcast for the third quarter of 2025. I'm here with our CEO, Roy Jacobs, and our CFO, Shalata Hanuman. The press release and the investor presentation can be accessed on our Investor Relations website. The replay and full transcript of this webcast will be available on our website after this call concludes. I want to draw your attention to our safe harbor statement on the screen and in the presentation. I will now hand over to Roy. Thanks, Durga. Good morning, everyone. Thank you for joining us today. We entered the third quarter with good momentum. We sustained it and delivered on plan for the quarter. Order intake grew 8%, marking the fourth consecutive quarter of improvement. It reflects the robust demand for products and our disciplined execution. Comparable sales growth stepped up sequentially to 3% year-on-year. All distances contributed to growth. Personal health delivered particularly strong performance. Adjusted EBITDA margin expanded by 50 basis points to 12.3%. in spite of the full quarter impact of currently imposed tariffs. It reflects solid gross margin delivery, driven by innovation, as well as the impact of our productivity and cost management. Overall, our performance in th...

More from Koninklijke Philips N.v.